Testing effectiveness (Phase 2)Looking for participantsNCT07118241
What this trial is testing
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
Who this might be right for
Sjögren's Syndrome
Lubris Bio Pty Ltd 80